Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decolonization of methicillin-resistant <i>Staphylococcus aureus</i> - effectiveness of decolonization treatment - ADDENDUM.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same author

Occurrence of acute respiratory illnesses in athletes: a systematic review and meta-analysis.

Exercise immunology review·2025
Same author

Third <i>Streptococcus pneumoniae</i> disease outbreak involving serotype 4-ST801 in a shipyard, Finland, May to June 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same author

Decolonization of methicillin-resistant <i>Staphylococcus aureus</i> - effectiveness of decolonization treatment.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same author

Vaccinations for Elite Athletes.

Vaccines·2025
Same author

Economic impact and disease burden of COVID-19 in a tertiary care hospital: A three-year analysis.

PloS one·2025
Same journal

Update on Current Care Guideline: Psoriasis (skin and joints).

Duodecim; laaketieteellinen aikakauskirja·2017
Same journal

FOUR score in monitoring the level of consciousness of an intensive care patient: first experience of the use of the Finnish language version.

Duodecim; laaketieteellinen aikakauskirja·2017
Same journal

Discussing a serious illness with a patient and family.

Duodecim; laaketieteellinen aikakauskirja·2017
Same journal

Invasive treatment of superficial veins of the lower extremities.

Duodecim; laaketieteellinen aikakauskirja·2017
Same journal

When should a drain be left in the abdominal cavity upon surgery?

Duodecim; laaketieteellinen aikakauskirja·2017
Same journal

Diagnostics and current care of myasthenia gravis.

Duodecim; laaketieteellinen aikakauskirja·2017
See all related articles

Related Experiment Video

Updated: May 22, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

[Group A streptococcal pneumonia].

Heikki Lukkarinen1, Harri Marttila, Juha Perttilä

  • 1TYKS, lastenklinikka.

Duodecim; Laaketieteellinen Aikakauskirja
|May 24, 2012
PubMed
Summary
This summary is machine-generated.

Group A betahemolytic streptococcus can cause severe pneumonia with toxic shock syndrome. Early clindamycin use may improve outcomes in this rare but serious infection.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Related Experiment Videos

Last Updated: May 22, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Group A betahemolytic streptococcus (GABHS) is a significant pathogen.
  • GABHS can lead to severe pneumonia, septic shock, and multiorgan failure.
  • This severe presentation is rare and can have delayed diagnosis and treatment.

Observation:

  • This study reports on four patients (two children, two adults) with GABHS pneumonia and toxic shock syndrome.
  • All patients required mechanical ventilation.
  • Three patients received clindamycin in addition to other antibiotics.

Findings:

  • All patients experienced a full recovery from the acute illness.
  • One patient developed permanent optic neuropathy, resulting in vision loss.
  • Clindamycin's role in restraining GABHS toxin production was utilized.

Implications:

  • Prompt diagnosis and aggressive treatment are crucial for GABHS-induced pneumonia and toxic shock syndrome.
  • Clindamycin may be a valuable adjunct therapy due to its effect on toxin production.
  • Healthcare providers should be vigilant for this rare but devastating condition.